Promising Times for Eli Lilly
Shares of drugmaker Eli Lilly have been on a steady rise, up approximately 50% in the past year. This positive momentum continued with a 1% gain on Monday and a…
EMA Investigates Risk of Suicidal Thoughts and Self-Harm from GLP-1 Receptor Agonists
The European Medicines Agency (EMA) announced on Tuesday that it is currently conducting a comprehensive review of data concerning the potential risk of suicidal thoughts and self-harm associated with the…